Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
44 巻, 5 号
選択された号の論文の39件中1~39を表示しています
EDITORIALS
ORIGINAL ARTICLES
  • Takashi WADA, Tsutomu FUKUMOTO, Mari JOKI, Toshihiko MAEDA, Kaoru NAKA ...
    2005 年 44 巻 5 号 p. 413-416
    発行日: 2005年
    公開日: 2005/06/06
    ジャーナル オープンアクセス
    Objective To demonstrate the correlation of six healthy habits with plasma glucose.
    Methods Our mnemonic or motto for promoting healthy habits is “none of one, less of two, more of three”. The ‘one’ behavior is smoking. The two things are intake of food and alcohol. The three things are exercise, rest and enjoyable activities.
    Subjects A questionnaire recording compliance with this motto was completed by 8,113 subjects undergoing medical health check-ups. Subjects under medication were excluded. Fasting plasma glucose was measured.
    Results Fasting plasma glucose decreased significantly in relation to the number of healthy habits practiced (5.57 mmol/l for one, 5.51 for two, 5.49 for three, 5.41 for four, 5.38 for five, and 5.31 for six).
    Conclusion Practicing these six healthy habits contributes to the prevention of diabetes mellitus.
  • Keiji YOSHIOKA, Toshihide YOSHIDA, Yasuto TAKAKURA, Tsunekazu UMEKAWA, ...
    2005 年 44 巻 5 号 p. 417-421
    発行日: 2005年
    公開日: 2005/06/06
    ジャーナル オープンアクセス
    Objective To clarify whether polymorphisms G1704T and G82S of the RAGE gene were related to diabetic retinopathy, we performed a case-control study in Japanese type 2 diabetic patients.
    Patients and Methods Two hundred and sixty-eight patients with type 2 diabetes were examined for polymorphisms G1704T and G82S of the RAGE gene. The genotypes of G1704T and G82S of the RAGE gene were determined with a fluorescent allele-specific DNA primer assay system. Diabetic retinopathy (DR) was diagnosed in a masked manner by independent ophthalmologists using fundus photographs and was classified as non-diabetic retinopathy (NDR), non-proliferative retinopathy (NPDR), and proliferative retinopathy (PDR).
    Results The T allele frequency of G1704T and S allele frequency of G82S in patients with DR did not significantly differ from those without retinopathy. There were no differences among the genotypes of G1704T and G82S of the RAGE gene regarding age, duration of diabetes, BMI, HbA1c, blood pressure, and lipids levels.
    Conclusion These data suggest that polymorphisms G1704T and G82S of the RAGE gene are not related to DR in Japanese type 2 diabetic patients.
  • Seiji KAWAHARA, Tsuneto AKASHIBA, Toshiki AKAHOSHI, Takashi HORIE
    2005 年 44 巻 5 号 p. 422-427
    発行日: 2005年
    公開日: 2005/06/06
    ジャーナル オープンアクセス
    Objective To assess changes in response to nasal continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea syndrome (OSAS) concerning excessive daytime sleepiness (EDS), depressive state, and quality of life (QOL).
    Patients and Methods We assessed for EDS using the Epworth sleepiness scale (ESS), for mood using The Zung self-depression scale (SDS), and for QOL using Short-Form 36 (SF-36) in 132 patients with obstructive sleep apnea syndrome (OSAS) and control subjects. Patients had severe OSAS (apnea-hypopnea index, 59.4±23.8/h) and were more hypersomnolent and depressed, and had poorer QOL than 38 age- and gender-matched controls.
    Results Before treatment most QOL domains in the SF-36 were significantly associated with patients’ SDS scores. With nasal CPAP, ESS and SDS scores were respectively decreased from 9.7±4.5 to 4.0±2.4 (p<0.0001) and from 49.2±10.4 to 45.1±9.6 (p<0.0005). Total SF-36 score and scores for seven of eight domains were increased significantly with treatment. Thus, nasal CPAP lessens EDS and depression, and improves QOL, in patients with severe OSAS. Further, magnitudes of changes in total SF-36 scores and in five of eight domains correlated significantly with magnitude of change in SDS score upon nasal CPAP treatment. No relationship was evident between treatment-associated score changes in SF-36 domains and ESS score change.
    Conclusion Although patients with severe OSAS have poorer QOL than control subjects, nasal CPAP appears to improve QOL by alleviating depression.
  • Masayuki MATSUDA, Toshiyuki YAMADA, Takahisa GONO, Yasuhiro SHIMOJIMA, ...
    2005 年 44 巻 5 号 p. 428-433
    発行日: 2005年
    公開日: 2005/06/06
    ジャーナル オープンアクセス
    Objective Immunoglobulin-related free light chains (FLCs) in serum have recently become quantitatively detectable using the nephelometric assay in plasma cell disorders, including multiple myeloma and AL amyloidosis. To investigate whether FLCs are useful as a diagnostic and therapeutic marker in Japanese patients with primary systemic AL amyloidosis, we determined these values in serum before and after chemotherapy.
    Patients and Methods The serum FLC analysis was carried out in 25 patients with primary systemic AL amyloidosis (mean age, 60.1±8.4 years). All of the patients were shown to have either ALê- or ALë-immunoreactive amyloid deposits on biopsied tissues. Thirteen patients were treated with VAD (vincristine, doxorubicin and dexamethasone) alone (n=6) or VAD and subsequent high-dose melphalan followed by autologous stem cell support (n=7), and serum FLCs were serially determined before and after the chemotherapy.
    Results Before chemotherapy the amyloidogenic FLC was elevated in serum with or without abnormal ê/ë ratios in 24 patients, including 5 with undetectable M-protein in both serum and urine on immunofixation. After chemotherapy the amyloidogenic FLC in serum was significantly decreased irrespective of high-dose melphalan (p<0.05), and all the patients with normalized ê/ë ratios showed a good prognosis.
    Conclusions With respect to sensitivity and quantification serum FLCs will be a key marker for diagnosis and therapeutic effects in primary systemic AL amyloidosis. The prognosis of patients with this disease may be improved if the ê/ë ratio in serum can be normalized by intensive chemotherapy.
  • Masahiro YASAKA, Ryoichi OTSUBO, Hiroshi OE, Kazuo MINEMATSU
    2005 年 44 巻 5 号 p. 434-438
    発行日: 2005年
    公開日: 2005/06/06
    ジャーナル オープンアクセス
    Objective Purpose was to assess the stroke mechanism in patients with patent foramen ovale (PFO).
    Methods We reviewed the medical records of 111 stroke patients with PFO and sinus rhythm (PFO-S group), 25 with PFO and atrial fibrillation (AF) (PFO-AF group) and 67 with AF but not PFO (AF group), who had received contrast transesophageal echocardiography. The clinical and neuroradiological findings were then compared among the three groups. Deep vein thrombosis was investigated in 93 patients with PFO. We determined the number of patients with definite paradoxical embolism who met three criteria: deep vein thrombosis, neuroradiological features indicating embolic stroke, and the absence of other sources of emboli. We also evaluated those with probable paradoxical embolism who met two of the three criteria.
    Results The PFO-S group more frequently exhibited hypercholesterolemia (p<0.0001) and lesions limited to the posterior circulation (p<0.0004), and less frequently exhibited large or cortical lesions in the anterior circulation (p=0.0008, p<0.0001, respectively), than the PFO-AF and AF groups. In the PFO-S and PFO-AF groups, other sources of emboli such as a cardiac source of emboli, cerebral artery stenosis ≥50%, or complicated atheroma in the aortic arch were identified in 72 cases (52.9%). In the 93 patients with examination for deep vein thrombosis, the definite and probable criteria of paradoxical embolism were fulfilled only in three (3.2%) and 33 cases (35.5%), respectively.
    Conclusion In stroke patients with PFO, not only paradoxical brain embolism through the PFO but also other causes of stroke may contribute to the development of stroke.
CASE REPORTS
SHORT COMMUNICATIONS
PICTURES IN CLINICAL MEDICINES
feedback
Top